Academic medical center and IRCCS research institute in Rome
Policlinico Gemelli is a 5,000+ person academic hospital and designated research institute (IRCCS) in Rome, operating across clinical care, rare disease diagnosis, oncology, and biomedical research. The tech stack reflects a research-first organization: R, Python, RStudio, GraphPad Prism, and SAS dominate, signaling heavy quantitative work in proteomics, molecular biology, and clinical data analysis rather than hospital operations software. Hiring velocity is accelerating across healthcare and research roles, with a senior-skewed seniority mix matching the complexity of advanced diagnostic development and high-acuity patient care.
Fondazione Policlinico Universitario Agostino Gemelli operates Rome's Policlinico Gemelli hospital in partnership with Università Cattolica del Sacro Cuore. Since its 2018 designation as an IRCCS (research hospital), it specializes in personalized medicine and innovative biotechnology. The hospital handles 40,000+ oncology procedures annually and serves as the reference center for the Lazio region in rare diseases, neuromuscullar conditions, and high-complexity clinical care. Active research spans proteomics, cancer biology, autoimmune disease mechanisms, and diagnostic innovation, supported by ongoing clinical studies and preclinical compound evaluation.
Policlinico Gemelli is a major academic hospital in Rome and an IRCCS institute (research designation since 2018) specializing in personalized medicine and biotechnology. It serves as the regional reference center for the Lazio region in rare diseases, neuromuscullar conditions, and high-complexity care, delivering 40,000+ oncology procedures yearly.
The research stack centers on R, Python, RStudio, GraphPad Prism, SAS, and ImageJ — tools optimized for biostatistics, proteomics, molecular analysis, and image processing rather than hospital administration systems.
Other companies in the same industry, closest in size